Literature DB >> 23696251

Report of a patient with developmental delay, hearing loss, growth retardation, and cleft lip and palate and a deletion of 7q34-36.1: review of distal 7q deletions.

Eric T Rush1, Jadd M Stevens, Warren G Sanger, Ann H Olney.   

Abstract

The use of aCGH has improved our ability to find subtle cytogenetic abnormalities as well as to find more precise information in patients with previously known abnormalities. In addition, it has allowed more specific genotype-phenotype correlation. In this report we describe a patient with a chromosomal deletion initially diagnosed with conventional cytogenetic analysis which was redemonstrated and more specifically described upon aCGH analysis. Our patient is a 12-year-old female born to a 26-year-old G1P0 mother. She was noted as a neonate to have a bilateral cleft lip and cleft palate, abnormal external ears, dysmorphic facies, and moderate to severe hearing loss. She has subsequently shown developmental delay, hyperreflexia, seizures, hyperactivity, and absence of speech. Chromosomal analysis showed deletion of 7q34q36.1. FISH studies confirmed the deletion was interstitial. Parental chromosomes were performed and did not show any cytogenetic abnormalities. aCGH was recently performed for the patient to further characterize the breakpoints of the deletion and confirmed the deletion was interstitial and of 13.2 Mb in size. Both proximal and terminal 7q deletion show a different phenotype than that of our patient. A number of patients with similar deletions have been found and while significant variability is observed, a number of findings appear to be common to deletions in this region. Therefore, we feel that distal interstitial deletions of chromosome 7q represent a recognizable phenotype and could be considered a separate deletion syndrome.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23696251     DOI: 10.1002/ajmg.a.35951

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  A case of germline mosaicism for a 7q32.1q33 deletion in a sperm donor: consequences on pregnancy follow-up and recommendations.

Authors:  Celine Chalas; Aline Receveur; Catherine Patrat; Francois Michael Petit; Nelly Frydman; Nathalie Massin; Gerard Tachdjian; Veronique Drouineaud; Alexandra Benachi
Journal:  Basic Clin Androl       Date:  2020-10-02

2.  Deletion of 7q33-q35 in a Patient with Intellectual Disability and Dysmorphic Features: Further Characterization of 7q Interstitial Deletion Syndrome.

Authors:  Kristen Dilzell; Diana Darcy; John Sum; Robert Wallerstein
Journal:  Case Rep Genet       Date:  2015-05-03

3.  Prenatal Diagnosis of Rare Familial Unbalanced Translocation of Chromosomes 7 and 12.

Authors:  Berrin Tezcan; Foteini Emmanouella Bredaki
Journal:  Case Rep Obstet Gynecol       Date:  2015-07-30

4.  An Interstitial Deletion at 7q33-36.1 in a Patient with Intellectual Disability, Significant Language Delay, and Severe Microcephaly.

Authors:  Trupti Kale; Melissa Philip
Journal:  Case Rep Genet       Date:  2016-12-08

Review 5.  Clinical, cytogenetic, and molecular findings in a fetus with ultrasonic multiple malformations, 4q duplication, and 7q deletion: A case report and literature review.

Authors:  Fagui Yue; Yuting Jiang; Yang Yu; Xiao Yang; Hongguo Zhang; Ruizhi Liu; Ruixue Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Case Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion.

Authors:  Liang-Liang Fan; Yue Sheng; Chen-Yu Wang; Ya-Li Li; Ji-Shi Liu
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

7.  Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies.

Authors:  Annette Uwineza; Jean-Hubert Caberg; Janvier Hitayezu; Anne Cecile Hellin; Mauricette Jamar; Vinciane Dideberg; Emmanuel K Rusingiza; Vincent Bours; Leon Mutesa
Journal:  BMC Med Genet       Date:  2014-07-12       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.